No Data
Piper Sandler Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Cuts Target Price to $2
X4 Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Maintains Target Price $1.5
Stifel Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Travere Therapeutics (TVTX), Treace Medical Concepts (TMCI) and X4 Pharmaceuticals (XFOR)
Stifel Nicolaus Remains a Buy on X4 Pharmaceuticals (XFOR)
WilsonVJR : Hi Jaguar, may I know whats PR refer to?
Jaguar8 OP WilsonVJR : press release
Jaguar8 OP WilsonVJR : read the NOTE before all the stocks
Juz give me my money : Thank You for your hardwork
JET_WoW : no longer interested in ptle?
View more comments...